Assessment of Effectiveness Ex-Press Surgery Modification

Status Completed

Clinical Trial Summary

The purpose of the study is to compare the effectiveness and safety profile of ExPress implantation versus partial deep sclerectomy combined with ExPress implantation with simultaneously phacoemulsification.

Clinical Trial Description

Mermoud et all (1) proposed a modification of the classical surgical technique: combined deep sclerectomy (DS) with ExPress device implantation. The goal of this modification was to enhance hypotensive effect of well known procedure, and also to simplify non-penetrating surgery, which is a procedure with a long learning curve. Mermoud's idea provides the possibility of avoiding complications related to dissection of the filtering bleb and gives hope for achieve of better results in comparison to the classical procedure. Thanks to this, the surgical procedure could be performed earlier, even in the case of glaucoma with low intraocular pressure (IOP), where vascular factors are largely responsible for the progression of neuropathy. To demonstrate the potential of both types of procedures with the application of the ExPress implant, the authors decided to conduct a prospective, randomized study with a 2-year observation period concerning the efficacy, safety and stability of effects achieved. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03800589
Study type	Interventional
Source	Military Institute of Medicine, Poland
Contact
Status	Completed
Phase	N/A
Start date	December 1, 2010
Completion date	December 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05044793` - A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
Recruiting	`NCT06201455` - Evaluation of Phacogoniotomy in Medically-controlled POAG	N/A
Recruiting	`NCT03369886` - The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AI	N/A
Active, not recruiting	`NCT04624698` - iStent Inject New Enrollment Post-Approval Study	N/A
Recruiting	`NCT02679482` - Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma	N/A
Completed	`NCT02338362` - Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma	Phase 4
Active, not recruiting	`NCT01430923` - Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost	N/A
Completed	`NCT01489670` - Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension	N/A
Completed	`NCT00693485` - Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy	Phase 2
Completed	`NCT00753168` - Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma	Phase 1/Phase 2
Completed	`NCT00051194` - A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension	Phase 2
Recruiting	`NCT04920227` - Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma	N/A
Active, not recruiting	`NCT03868124` - Clinical Study Comparing Two Models of a Travoprost Intraocular Implant	Phase 3
Completed	`NCT03267862` - Scleral Response to Intraocular Pressure (IOP)	N/A
Recruiting	`NCT06066645` - Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone	Phase 3
Recruiting	`NCT04912362` - The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma	N/A
Completed	`NCT04949802` - Glaucoma Surgery Using the ViaLase Laser System	N/A
Recruiting	`NCT04038034` - Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma	N/A
Completed	`NCT04632329` - Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma	N/A
Completed	`NCT01215786` - Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma	Phase 1